Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$153M |
| 2 |
GE Vernova
GEV
|
+$129M |
| 3 |
Ferrovial N.V. Ordinary Shares
FER
|
+$61.6M |
| 4 |
Solventum
SOLV
|
+$26.3M |
| 5 |
Strategy Inc
MSTR
|
+$25.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$104M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Meta Platforms (Facebook)
META
|
+$77.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.83% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBOW
2026
DELISTED
SilverBow Resources, Inc.
SBOW
| $1.33M | ﹤0.01% |
35,100
| – | – |
|
2027
Univest Financial
UVSP
$1.19B
| $1.33M | ﹤0.01% |
58,078
| – | – |
|
2028
Edgewise Therapeutics
EWTX
$4.69B
| $1.33M | ﹤0.01% |
73,600
+6,300
| +9% | +$110K |
|
|
NPKI
2029
NPK International
NPKI
$1.18B
| $1.33M | ﹤0.01% |
159,500
| – | – |
|
2030
Praxis Precision Medicines
PRAX
$10.3B
| $1.32M | ﹤0.01% |
+32,000
| New | +$1.51M |
|
|
EFXT
2031
Enerflex
EFXT
$2.62B
| $1.32M | ﹤0.01% |
245,500
| – | – |
|
2032
Community Trust Bancorp
CTBI
$1.44B
| $1.32M | ﹤0.01% |
30,190
| – | – |
|
|
MCW
2033
DELISTED
Mister Car Wash
MCW
| $1.32M | ﹤0.01% |
184,800
| – | – |
|
2034
Amplitude
AMPL
$1.66B
| $1.32M | ﹤0.01% |
147,800
+15,700
| +12% | +$147K |
|
2035
First Mid Bancshares
FMBH
$1.39B
| $1.32M | ﹤0.01% |
40,000
-2,400
| -6% | -$75.4K |
|
2036
International Money Express
IMXI
$353M
| $1.32M | ﹤0.01% |
63,100
-2,300
| -4% | -$48.4K |
|
|
DAWN
2037
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.31M | ﹤0.01% |
95,400
| – | – |
|
2038
Dream Finders Homes
DFH
$1.35B
| $1.31M | ﹤0.01% |
50,900
+2,200
| +5% | +$69.5K |
|
2039
Old Second Bancorp
OSBC
$1.31B
| $1.3M | ﹤0.01% |
88,000
| – | – |
|
2040
ZipRecruiter
ZIP
$388M
| $1.3M | ﹤0.01% |
143,300
+15,500
| +12% | +$156K |
|
|
PRA
2041
DELISTED
ProAssurance
PRA
| $1.3M | ﹤0.01% |
106,300
+5,700
| +6% | +$77.4K |
|
2042
Riskified
RSKD
$863M
| $1.3M | ﹤0.01% |
203,213
+20,000
| +11% | +$113K |
|
|
SHOE
2043
Shoe Station Group
SHOE
$415M
| $1.29M | ﹤0.01% |
35,100
| – | – |
|
2044
Tarsus Pharmaceuticals
TARS
$3.02B
| $1.29M | ﹤0.01% |
47,333
+4,900
| +12% | +$165K |
|
2045
Smith & Wesson
SWBI
$643M
| $1.28M | ﹤0.01% |
89,550
-1,300
| -1% | -$21.3K |
|
2046
Radware
RDWR
$1.25B
| $1.28M | ﹤0.01% |
70,400
-4,500
| -6% | -$82.2K |
|
2047
Cullinan Oncology
CGEM
$1.26B
| $1.28M | ﹤0.01% |
73,600
+27,300
| +59% | +$581K |
|
2048
Mercantile Bank Corp
MBWM
$1.06B
| $1.28M | ﹤0.01% |
31,600
| – | – |
|
2049
MarineMax
HZO
$1.15B
| $1.28M | ﹤0.01% |
39,600
| – | – |
|
|
SPTN
2050
DELISTED
SpartanNash
SPTN
| $1.28M | ﹤0.01% |
68,280
| – | – |
|
Similar funds
Swiss National Bank's Q2 2024 Portfolio in Review
As of Q2 2024, Swiss National Bank held 2,546 positions worth $146B, up 2% from $143B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Swiss National Bank's Q2 2024 filing shows 41 new, 569 increased, 1,097 reduced and 88 closed positions. Its largest new stake was GE Vernova: 811,465 shares worth $139M. The largest sale was Pioneer Natural Resource Co., an estimated $184M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2024 buy was GE Vernova: 811,465 shares worth $139M.
- Swiss National Bank added most to ExxonMobil in Q2 2024, an estimated $153M increase.
- Swiss National Bank's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $135M.
- Swiss National Bank fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $184M.
- Swiss National Bank's ten largest holdings make up 33% of its $146B portfolio in Q2 2024.
- Swiss National Bank opened 41 new positions and closed 88 in Q2 2024.
- Swiss National Bank's portfolio value rose 2% quarter-over-quarter to $146B.
Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.